Gilead Sciences (GILD) PT Raised to $86 at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $165.61 +4.03%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 27 | New: 16
Join SI Premium – FREE
Cantor Fitzgerald analyst Alethia Young raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $78.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Gilead Sciences (GILD) Tops Q3 EPS by 38c; revises guidance
- Insmed (INSM) PT Lowered to $195 at Stifel
- Boeing (BA) PT Lowered to $240 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
